<DOC>
	<DOCNO>NCT00850798</DOCNO>
	<brief_summary>Aims/hypothesis : Populations worldwide age type 2 diabetes common individual age &gt; 80 year . The important issue need consider whether tight glycemic control benefit elderly patient type 2 diabetes . The benefit intensive glucose control remain uncertain heterogeneous population older diabetic patient due lack clinical trial data evaluate benefit long-term intensive glucose control old patient . This study design provide reliable evidence balance benefit risk confer intensive glucose control elderly patient type 2 diabetes Methods : This prospective , randomize , open-labeled , control design ass benefit treat elderly patient type 2 diabetes . The study include 208 elderly patient type 2 diabetes follow-up 5 year . Eligible patient randomize receive intensive ( A1C &lt; 7.0 % ) conservative ( A1C around 8.0 % ) glycemic control . The primary study outcomes composite macrovascular event composite microvascular event , consider jointly separately . The secondary outcome death cause , death cardiovascular cause , total coronary event , total cerebrovascular event , heart failure , peripheral vascular event , cardiovascular event , hospitalization 24 hour . Expected result : This study design provide reliable evidence balance benefit risk confer intensive conservative glucose control elderly patient type 2 diabetes . Once complete , trial clearly influence management elderly patient type 2 diabetes , regardless result .</brief_summary>
	<brief_title>The Benefits Intensive Glycemic Control Elderly Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men woman age ≥80 year time randomization.There upper age limit . Be able walk They first diagnosis type 2 diabetes mellitus age 30 year old . Known advance diabetic complication ( proliferative retinopathy , chronic kidney disease stage IV ) . Overt clinical congestive heart failure ( CHF ) require treatment diuretic ACE inhibitor . Previous documented cerebral subarachnoid haemorrhage last 6 month Condition expect severely limit survival Clinical diagnosis dementia Resident nursing home</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Elder patient</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Men woman age ≥80 year time randomization . There upper age limit .</keyword>
	<keyword>Be able walk</keyword>
	<keyword>They first diagnosis type 2 diabetes mellitus age 30 year old .</keyword>
</DOC>